ClinicalTrials.Veeva

Menu

[S,S]-Reboxetine Dose-Range Finding Trial

Pfizer logo

Pfizer

Status and phase

Completed
Phase 2

Conditions

Pain

Treatments

Drug: [S,S]-Reboxetine

Study type

Interventional

Funder types

Industry

Identifiers

NCT00288652
A6061026

Details and patient eligibility

About

The purpose of this study is to determine the effectiveness of different doses of [S,S]-Reboxetine in the treatment of chronic pain following a shingles infection

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients must have pain present for more than 3 months after the healing of shingles skin rash
  • Patients at screening must have a score >/=40 mm on the pain visual analogue scale

Exclusion criteria

  • Patients with significant renal and hepatic impairment
  • Patients with other severe pain, that may impair the self-assessment of the pain due to shingles
  • Patients with clinically abnormal electrocardiogram

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

Trial contacts and locations

79

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems